CTRI/2026/07/114178进行中（未招募）不适用
A non-randomized, evaluator-blinded, single center study to evaluate the dermatological safety of Test Products by Primary Irritation Patch Test on Adult Healthy Human Participants with Sensitive Skin - NIL
Dabur Research and Development Center0 个研究点目标入组 26 人开始时间: 2026年8月3日最近更新:
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 26
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Males and non-pregnant non-lactating females between age group of 18 to 65 years at the time of consent.
- •Participants with normal Fitzpatrick skin type III to V.
- •Females of childbearing potential must have a negative urine pregnancy test performed on Day 01 prior to patch application.
- •Participants scoring greater than 30 for Section 2- Sensitive vs Resistant skin in modified Dr. Baumanns skin type questionnaire.
- •Participants who do not have any previous history of adverse skin conditions and are not under any medication are likely to interfere with the results.
- •Participants are in good general health as determined by the Investigator on the basis of medical history.
- •Participants willing to maintain the test patches in designated positions for 24 Hours and refrain from vigorous physical exercise during the study period.
- •Participants willing and able to follow the study directions to participate in the study, return for all specified visits.
- •Participants must be able to understand and provide written informed consent to participate in the study.
- •Participants should be literate and able to read and write.
- •Participants having valid proof of identity and age.
排除标准
- •Participants having skin irritation, blemishes, excessive hair, moles, pigmentation, pimples, marks, open wounds, cuts, abrasions, irritation symptoms or any dermatological condition on the test site i.e., back that can interfere with the reading.
- •Participant with history of asthma or COPD, diabetes and mastectomy for cancer involving removal of lymph nodes within the past year, or treatment of any type of cancer within the last 6 months.
- •Participant suffering from any active clinically significant skin diseases which may affect the study results.
- •Participant having history of any skin diseases including eczema, atopic dermatitis.
- •Participation in any patch test for irritation or sensitization within the last four weeks.
- •Participants taking part in another study liable to interfere with the results of this study.
- •Participants with self-reported Immunological disorders such as HIV positive, AIDS and systemic lupus erythematous.
- •Participants with a medical condition or are taking or have taken a medication which, in the Investigator s judgment, makes the participant ineligible or places the participant at undue risk.
- •Participant with known allergy or sensitization to medical adhesives, bandages.
- •Use of any,
- •Prescribed or over-the-counter anti-inflammatory drug within five days prior to application.
- •Antihistamine medication or immunosuppressive drugs within seven days prior to first patch application.
- •Systemic or topical corticosteroids at patch site within four weeks of test product application
- •Topical drugs used at application site.
研究组 & 干预措施
Intervention1: DRDC/2026/010: Neat, 0.04mg, single dose, topical application, 24 hr
干预措施: Intervention1: DRDC/2026/010: Neat, 0.04mg, single dose, topical application, 24 hr
研究者
相似试验
招募中
不适用
Phase III study of KD2-396Prevention of pertussis, diphtheria, tetanus, poliomyelitis(polio), Hib infection, and hepatitis BjRCT2031250804540
招募中
不适用
A Prospective Comparative Study Evaluating the Effectiveness of a Novel Endoscopic Resection Technique (Tip-in UEMR) for Superficial Duodenal Tumors Measuring 10-20 mmSuperficial non-ampullary duodenal epithelial tumor (SNADET)jRCT105225018376
招募中
不适用
A Multi-center, single-blind, Randomized Controlled Trial Comparing Interrupted vs Continuous Fascial Closure in the Mini-laparotomy Incision During Laparoscopic or Robot-assisted Colorectal Resection (CLOSURE-CR trial)Colorectal neoplastic lesions including colorectal cancer, appendiceal tumors, neuroendocrine tumorjRCT1030260304900
招募中
不适用
A study to evaluate the efficacy and safety of ELGN-2112 on intestinal malabsorption in preterm infants as compared to placebo. (FIT-PIV)Intestinal Malabsorption in Preterm InfantsjRCT203126028220
招募中
不适用
A Phase III Study of M610101 in Patients with Atopic DermatitisAtopic dermatitisjRCT2031260244150